Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer
Chan-Young Ock, Shin-Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo
Korean J Intern Med. 2019;34(5):1116-1124.   Published online 2018 Jun 29     DOI: https://doi.org/10.3904/kjim.2018.011
Citations to this article as recorded by Crossref logo
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer
Yen-Ting Lin, Yi-Nan Liu, Jin-Yuan Shih
Frontiers in Oncology.2019;[Epub]     CrossRef